X

Week in review: The latest from PhRMA

Priscilla VanderVeer   |     February 26, 2016   |   SHARE THIS

week-in-review.jpg
A decade of progress in chronic disease: Significant progress has been made in the last 10 years in the fight against chronic diseases. Learn more in a new report, “A Decade of Innovation in Chronic Diseases.”

Fighting neglected tropical disease:  Patients with neglected tropical diseases face many challenges, including challenges getting diagnosed and the available treatment options. Read more from guest contributors Jill Wood and Sean Elkins as they encourage researchers, patient and advocates of both types of disease to join forces in pursuit of diagnostic best practices and ultimately a set of cures.

Amyloidosis diseases and unmet medical needs:   Amyloidosis is a rare disorder caused by proteins that possess abnormal conformational features leading them to aggregate and infiltrate tissues in the form of amyloid fibrils. This week, we featured a guest post from Isabelle Lousada, president and CEO of the Amyloidosis Research Consortium, highlighting  the unmet medical needs of amyloidosis and why successful collaborations across sectors are needed to advance  science and understanding of these diseases.

Hope in innovation: We often talk about the immeasurable impact of innovations in pharmaceutical research and development. This week, our guest contributor, Jamie Pires, a chronic myelogenous leukemia patient, shared her journey from unexpected diagnosis and painful treatment to how a new treatment changed her outlook.

Medicare Monday: This Monday, we took a look at two claims about Medicare Part D: what the critics said would happen, and what actually happened.
Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

Subscribe to Email Updates